Advance
Preprints are early versions of research articles that have not been peer reviewed. They should not be regarded as conclusive and should not be reported in news media as established information.
1Advance a preprint of final_submitted_MS_Main_Document_md.pdf (928.74 kB)
0/0

The current status, trend and development strategies of the biopharmaceutical industry with a challengingperspective of Chinese industry

Download (928.74 kB)
preprint
posted on 26.08.2019 by Kerong Zhang, Wuyi Liu
Biopharmaceutical technology is one of the most promising biotechnologies in the world. With the development of modern biotechnology, biopharmaceuticals are thriving and developing rapidly in the world as a high-tech biotechnology industry, bringing unprecedented market prospects to biopharmaceuticals in China and the world. Chinese biopharmaceutical industry is booming and growing up. The national biopharmaceutical industry of China, especially the development and industrialization with genetic engineering drugs as its core fields, has already reached a certain market scale after nearly 20 years of development. The biopharmaceutical industry will be one of the most active economic sectors in China, whereas the biotechnological revolution with modern biopharmaceutical technology has become the lifeblood of maintaining human health and food safety in the future. The article explores the current status, trend, existing problems and development strategies of the biopharmaceutical industry and industrial bases in China.

History

Declaration of conflicts of interest

The authors declare that there is no conflict of interests.

Corresponding author email

lwycau@163.com

Lead author country

China

Lead author job role

Higher Education Researcher

Lead author institution

Fuyang Normal University

Human Participants

No

Licence

Exports

Comments

Log in to write your comment here...